School of Medicine


Showing 1-32 of 32 Results

  • Daniel Chang

    Daniel Chang

    Sue and Bob McCollum Professor

    Current Research and Scholarly Interests I specialize in the treatment of gastrointestinal malignancies. I am interested in developing stereotactic body radiotherapy for tumors of the liver, both primary and metastatic. I am interested in developing functional imaging as a means of determining treatment response with radiation. I am also interested in developing image-guided radiotherapy to improve radiation delivery for GI cancers to reduce toxicity and improve disease outcome.

  • Rishabh Chaudhari, MD

    Rishabh Chaudhari, MD

    Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

    Bio Dr. Chaudhari is a radiation oncologist with the Stanford Medicine Cancer Center and a clinical assistant professor in the Department of Radiation Oncology at Stanford University School of Medicine.

    He specializes in delivering image-guided interventions for all forms of cancer, including lung, breast, prostate, and head and neck. He treats conditions including mesothelioma, seminoma, renal cell carcinoma, and vulvar cancer.

    In every case, he develops a comprehensive, compassionate care plan personalized to the unique needs of each patient. His goal is always to deliver innovative, compassionate care of the highest quality to help each patient achieve the best possible outcome.

    Dr. Chaudhari conducts research into leading-edge treatments, allowing him to offer the most advanced care options. He has investigated stereotactic body radiation therapy for non-small cell lung cancer and for pancreatic adenocarcinoma. He has also studied the effects of radiotherapy on breast cancer stem cells and extramedullary plasmacytomas. He also is currently studying the use of proton beam therapy on recurrent head and neck cancers.

    Dr. Chaudhari has presented his research findings at meetings of the Radiation Research Society, Society for Thermal Medicine, American Society for Radiation Oncology, and World Congress of Brachytherapy. He has published articles on radiotherapy for non-small cell lung cancer in the journal Lung Cancer: Targets and Therapy. He also co-authored the chapter ?Renal and Adrenal Vasculature: Anatomy and Imaging? in the textbook Image-Guided Interventions. He is a reviewer for Cancer Medicine.

    In previous positions, Dr. Chaudhari served on committees dedicated to care quality assurance and to the monitoring of cancer care protocols. Other areas of interest include radiation oncology department operations and advising radiation oncology residents.

    Dr. Chaudhari is a member of the American Society for Radiation Oncology.

  • Alexander Chin, MD, MBA

    Alexander Chin, MD, MBA

    Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

    Bio Alexander Chin, MD, MBA, is radiation oncologist and a clinical assistant professor in the Department of Radiation Oncology. He is also the Stanford Health Care Director of Market Development, serving as the liaison between radiation oncology faculty leadership and hospital administration, to ensure that the communities we serve are fully aware of, and have access to, the cancer care services of Stanford Health Care.

    Dr. Chin is committed to ensuring the delivery of care of the highest quality and value. He provides clinical expertise in diagnosing and treating the full range of cancers, including those of the breast, head, neck, and lung. In addition, he serves on national leadership teams formed to advance the practice of cancer care. Dr. Chin is currently a member of the payment reform task force for the American Society of Clinical Oncology and has previously served on their clinical practice committee and as a health policy fellow. He was one of just two oncologists in the US selected to participate in a year-long program on policy leadership.

    He currently serves on the Stanford Cancer Network quality committee. This team develops and implements our care delivery standards, strategies, and metrics to ensure consistently excellent cancer care from all Stanford Health Care providers in all locations.

    Dr. Chin has conducted extensive research and published his findings in numerous peer-reviewed journals. Topics range from gene expression in vaginal cancer to payment models and formulary management issues. His scholarship appears in Advances in Radiation Oncology, Cancer, JCO Oncology Practice, International Journal of Gynecological Pathology, Health-System Pharmacy, and elsewhere.

    He has made presentations on stereotactic body radiotherapy (SBRT) and other treatment advances at meetings of the Radiological Society of North America and American Society for Radiation Oncology. He also has addressed these topics as an invited lecturer in training sessions for oncology residents.

    He has won numerous awards, including recognition for his research from the Radiological Society of North America. He also has earned honors from the American Society of Clinical Oncology and from his alma maters: the Perelman School of Medicine at the University of Pennsylvania as well as Wharton and Yale.

    Dr. Chin earned a Bachelor of science degree in molecular biophysics and biochemistry from Yale University. He earned his medical degree from Perelman School of Medicine at the University of Pennsylvania, and his MBA at the Wharton School. He completed his residency in Radiation Oncology at Stanford Health Care.

    He is a member of the Radiological Society of North America, American Society for Radiation Oncology, American Society for Clinical Oncology, and American Brachytherapy Society.

  • Maximilian Diehn, MD, PhD

    Maximilian Diehn, MD, PhD

    Associate Professor of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly Interests My laboratory focuses on two main areas: 1) cancer stem cell biology and 2) novel biomarkers for identifying the presence of malignant cells (diagnostic), predicting outcome (prognostic), and predicting response to therapy (predictive). Areas of study include cancers of the lung, breast, and gastrointestinal system. Clinically I specialize in the treatment of lung cancer and applications of stereotactic ablative radiotherapy and perform both prospective and retrospective clinical studies.

  • Sarah S. Donaldson, MD

    Sarah S. Donaldson, MD

    Catharine and Howard Avery Professor in the School of Medicine

    Current Research and Scholarly Interests Combined Modality Treatment of Cancer
    Late Effects of Treatment
    Genetic Effects of Cancer
    Rhabdomyosarcoma
    Hodgkins Disease
    Pediatric Radiation Oncolgy
    Pediatric Oncolgy
    Breast Cancer
    Conformal Radiotherapy/IMRT
    Radiotherapy for Benign Diseases

  • Iris C. Gibbs, MD, FACR, FASTRO

    Iris C. Gibbs, MD, FACR, FASTRO

    Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Gibbs is a board-certified radiation oncologist who specializes in the treatment of CNS tumors. Her research focuses on developing new radiation techniques to manage brain and spinal tumors in adults and children. Dr. Gibbs has gained worldwide acclaim for her expertise in Cyberknife robotic radiosurgery.

  • Steven Hancock, MD

    Steven Hancock, MD

    Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery at Stanford University Medical Center

    Current Research and Scholarly Interests Outcomes of radiation treatment for prostate cancer. Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.
    General adult and pediatric radiation therapy.

  • Richard Hoppe

    Richard Hoppe

    Henry S. Kaplan-Harry Lebeson Professor of Cancer Biology

    Current Research and Scholarly Interests Irradiation immunosuppression; total body irradiation;, psychosocial effects of cancer treatment; treatment of lymphoma;, mycosis fungoides.

  • Daniel Kapp

    Daniel Kapp

    Professor of Radiation Oncology, Emeritus

    Current Research and Scholarly Interests Gynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.

  • Susan Knox

    Susan Knox

    Associate Professor of Radiation Oncology, Emerita

    Current Research and Scholarly Interests Our interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.

  • Quynh-Thu Le, MD

    Quynh-Thu Le, MD

    Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)

    Current Research and Scholarly Interests My laboratory research interest focuses on the identification of biomarkers for prognosis in patients with head & neck or lung cancers. I am also conducting a number of clinical trials specifically in patients with head & neck cancers.

  • Billy W. Loo, Jr., MD, PhD, DABR

    Billy W. Loo, Jr., MD, PhD, DABR

    Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center

    Current Research and Scholarly Interests My clinical specialty is radiation treatment of thoracic cancers.

    My research is on developing next-generation ultra-rapid radiation therapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.

    My clinical research is on advanced 4-D image-guided radiation therapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers.

  • Andrew Philip Martella

    Andrew Philip Martella

    Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

    Bio Dr. Martella is a fellowship-trained radiation oncologist and a clinical assistant professor of radiation oncology at Stanford University School of Medicine.

    His clinical interests include gynecologic, breast, thoracic, gastrointestinal, genitourinary, and central nervous system cancers. His experience encompasses the full range of radiotherapy techniques, including intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic body radiotherapy (SBRT), CyberKnife radiosurgery, eye plaque brachytherapy, and prostate and gynecologic high dose rate (HDR) brachytherapy.

    Dr. Martella is dedicated to improving the quality of care and the patient experience. He deeply values a close relationship with his patients and their loved ones. He feels that each patient experiences healthcare in a unique and individual way. By recognizing and responding to those individual needs Dr. Martella provides a truly patient-centered experience. He has helped conduct research into noninvasive deep brain stimulation and chromosomal topography,and published on the topic of treating rectal cancer without radiation. He also was the primary contributing author of chapters in the book First Aid for the United States Medical Licensing Examination.

    Dr. Martella has delivered presentations at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Topics include chemotherapy and radiotherapy in endometrial cancer.

    Among the honors for scholarship that Dr. Martella has received, he graduated first in his class at Duke University School of Medicine. He was also elected during medical school into Alpha Omega Alpha Honor Medical Society.

    Dr. Martella?s community service has included a position on the board of directors of Camp Good Days and Special Times, a nonprofit organization that provides services for children who have cancer, have a parent or sibling with cancer, or have lost a parent or sibling to the disease. He has served on several leadership roles and has a deep dedication to furthering diversity and inclusion throughout the healthcare system.

  • Lynn Million

    Lynn Million

    Clinical Professor, Radiation Oncology - Radiation Therapy

    Bio Lynn Million specializes in the treatment of cancer. She has practiced Radiation Oncology for more than 30 years. Dr. Million has a special interest in the treatment of sarcoma?s of soft tissue, bone and cartilage in children, young adolescents and adults.

  • Everett J. Moding, MD, PhD

    Everett J. Moding, MD, PhD

    Assistant Professor of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly Interests My laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.

  • Prithvi Mruthyunjaya, MD, MHS

    Prithvi Mruthyunjaya, MD, MHS

    Associate Professor of Ophthalmology and, by courtesy, of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
    His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
    In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy.

  • Scott G. Soltys, MD

    Scott G. Soltys, MD

    Associate Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery at the Stanford University Medical Center

    Current Research and Scholarly Interests My clinical and research interests focus on the development of new radiation techniques involving stereotactic radiosurgery and radiotherapy for the treatment of malignant and benign tumors of the brain and spine, as well as functional disorders such as trigeminal neuralgia.

  • Lucas Kas Vitzthum

    Lucas Kas Vitzthum

    Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

    Bio Dr. Vitzthum is a radiation oncologist and clinical assistant professor of radiation oncology at Stanford University School of Medicine. He specializes in the treatment of gastrointestinal and thoracic cancers. He also has a clinical and research interest in oligometastatic cancer, which is cancer that has metastasized to a limited number of sites beyond its origin.

    He began his career in biomedical engineering and is passionate aboutintegrating new technologies to advance patient care.

    Dr. Vitzthum delivers treatment personalized to each patient?s condition, overall health, and goals. He believes clear communication between doctor and patient is vital to help patients make informed care decisions.

    His research interests include clinical trial development, survivorship, and predictive modeling to personalize patient treatment. He is especially interested in pursuing research that can address unmet clinical needs.

    Dr. Vitzthum has received research support through the Radiological Society of North America, the American Society of Clinical Oncology?s Conquer Cancer Foundation, and the UCSD Altman Clinical and Translational Research Institute. His work has appeared in International Journal of Radiation Oncology Biology Physics, Annals of Oncology, JAMA Oncology, Clinical Cancer Research, and other publications.

    He is a member of the American College of Radiation Oncology, American Society for Radiation Oncology, American Society of Clinical Oncology, and Radiologic Society of North America.

    Dr. Vitzthum is also interested in improving access to high-quality cancer care for under-served populations domestically and abroad.

  • Sandra Zaky

    Sandra Zaky

    Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

    Bio Dr. Zaky is a board certified Radiation Oncologist. She received a Bachelor?s of Science in Biomedical/Electrical Engineering at Marquette University. She worked in research and development as an Engineer, and eventually received a Masters of Science in Immunology from Albany Medical College. Her research thesis focused on a novel therapy to treat hormone-receptor positive breast cancer. She continued to study breast cancer with her research during her Radiation Oncology residency; she integrated her research in the laboratory with her clinical research in triple-negative breast cancer. Since completing residency, she has worked as a general radiation oncologist, and her special interests include breast cancer, skin cancer, CNS tumors and stereotactic radiotherapy.

Footer Links:

Stanford Medicine Resources: